OpenJournalRank

Journal rankings · indicator year 2012

Choose a field to open its ranking, or a journal to find its row in its subfield’s list.

Field ranking · 2012

Medicine journal rankings 2012

3,131 ranked journals · Field in Health Sciences

Medicine has 3,131 ranked journals in 2012. The median journal has an OJR of 0.76, below the world average of 1.00, up 0.01 on 2011; Q1 starts at OJR 1.32. The top three are CA A Cancer Journal for Clinicians, New England Journal of Medicine, and Clinical Microbiology Reviews.

Ranks and citation indicators: 2012. Journal access status and listed APC: source snapshot September 23, 2026.

Ranked journals

Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2009–2011, the window the 2012 score is computed on.

3,131
82% of Health Sciences
Median OJR

The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.

The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.

The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.

0.76+0.01 vs 2011
This fieldAll 0.94World 1.00
Open-access journals

Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.

30%
All fields: 24%
Median listed APC

Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.

$3,490
Median positive listed APC: $3,490 among 1,656 journals. Another 21 list $0; 1,454 have no known price. All fields: $3,413.

Subfields in Medicine (42)

Up to Health Sciences
Show all 42 subfields

3,131 ranked journals

Filters

Quartile

Quartiles split the ranked journals of the list you are viewing into four equal groups by OJR. Q1 is the top quarter and Q4 the bottom quarter.

They are computed within the list on screen, so a journal can be Q1 in its subfield and Q2 in the global ranking.

Access
APC (list price)
Loading every ranked journal in this list…
Medicine ranking, 2012

Rank is the position by OJR within the list on screen; 1 is the highest.

OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields.

The badge is the journal’s quartile in this list.

OJR

Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field.

▲ or ▼ is the change from 2011. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor.

Citable documents (articles, reviews and conference papers) published in 2009–2011, the window the 2012 OJR is computed on. A journal needs at least 30 to be ranked.

Share of the journal’s 2009–2011 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal.

List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed.

The line is the journal’s OJR from 2003 to 2012.

Compare
1CA A Cancer Journal for CliniciansOAWiley · United States
56.47Q1196.93 85.70 up from 201171100%$4,330
2New England Journal of MedicineMassachusetts Medical Society · United States
14.48Q126.42 0.69 down from 20112,86337%—
3Clinical Microbiology ReviewsAmerican Society for Microbiology · United States
11.28Q125.06 2.92 up from 2011103100%—
4Endocrine ReviewsOxford University Press · United States
8.66Q114.45 9.48 down from 201110150%$3,750
5Archives of General PsychiatryAmerican Medical Association · United States
8.12Q115.60 1.17 up from 201148556%—
6Cancer CellCell Press · Netherlands
7.11Q120.07 0.63 up from 2011465100%$10,400
7The Lancet NeurologyElsevier BV · Netherlands
6.98Q116.56 0.25 up from 201153644%$7,280
8CirculationLippincott Williams & Wilkins · United States
6.76Q114.84 0.07 up from 20112,64220%—
9The Lancet OncologyElsevier BV · United Kingdom
6.40Q114.09 0.09 down from 201171410%$7,280
10Journal of the American College of CardiologyElsevier BV · United States
6.31Q112.73 0.82 down from 20112,04298%$7,166
11PLoS MedicineOAPublic Library of Science · United States
6.14Q112.27 0.11 up from 2011586100%$6,460
12Journal of Clinical OncologyLippincott Williams & Wilkins · United States
5.98Q113.68 1.24 down from 20113,1359%—
13MMWR Morbidity and Mortality Weekly ReportOACenters for Disease Control and Prevention · United States
5.50Q19.52 1.40 down from 2011450%—
14European Heart JournalOxford University Press · United Kingdom
5.38Q114.44 4.32 up from 20111,18143%$5,922
15Natural Product ReportsRoyal Society of Chemistry · United Kingdom
5.33Q111.11 0.85 up from 201123015%—
16Progress in Retinal and Eye ResearchElsevier BV · Netherlands
5.29Q19.74 0.57 down from 20118352%$6,710
17Nature MedicineNature Portfolio · United States
5.19Q110.41 0.32 down from 20111,32433%$12,690
18European UrologyElsevier BV · Switzerland
4.84Q110.13 0.61 up from 20118809%$5,250
19BrainOxford University Press · United Kingdom
4.56Q110.65 0.26 down from 201194861%$5,570
20Annals of NeurologyWiley · United States
4.53Q110.51 0.01 down from 201184539%$4,700
21Sports MedicineSpringer Science+Business Media · Switzerland
4.38Q17.22 0.36 up from 201119419%$5,790
22Alzheimer s & DementiaWiley · United States
4.35Q112.66 6.25 up from 201127624%$4,200
23PLoS PathogensOAPublic Library of Science · United States
4.22Q19.96 1.02 down from 20111,556100%$3,043
24Diabetes CareAmerican Diabetes Association · United States
4.19Q19.48 0.20 up from 20111,83499%—
4.15Q17.48 1.30 down from 201122365%—
26The American Journal of Sports MedicineSAGE Publishing · United States
4.11Q16.69 0.58 up from 201192512%$4,400
27JNCI Journal of the National Cancer InstituteOxford University Press · United States
4.10Q110.85 0.67 up from 201164848%$5,436
28The Lancet Infectious DiseasesElsevier BV · Netherlands
4.09Q112.55 0.68 up from 201146331%$7,280
29Archives of Internal MedicineAmerican Medical Association · United States
4.02Q15.99 2.21 down from 20111,37122%—
30Seminars in Liver DiseaseThieme Medical Publishers (Germany) · United States
4.01Q19.76 0.54 up from 201112514%—
31PEDIATRICSAmerican Academy of Pediatrics · United States
3.98Q17.09 0.33 down from 20112,44618%—
32Acta NeuropathologicaSpringer Science+Business Media · Germany
3.91Q19.82 0.44 down from 201141761%$4,990
33GastroenterologyElsevier BV · United States
3.85Q18.75 0.24 down from 20111,86439%$4,180
34BMC MedicineOABioMed Central · United Kingdom
3.83Q111.07 0.85 up from 2011308100%$4,190
35DiabetesAmerican Diabetes Association · United States
3.76Q18.32 0.26 down from 20111,14493%—
36Medical Image AnalysisElsevier BV · United Kingdom
3.74Q15.23 1.14 down from 201122743%$4,170
37American Journal of Respiratory and Critical Care MedicineAmerican Thoracic Society · United States
3.70Q17.88 0.55 down from 20111,49132%—
38Annals of the Rheumatic DiseasesBMJ · United Kingdom
3.67Q19.44 1.20 up from 20111,13011%$4,870
39AutophagyTaylor & Francis · United States
3.63Q19.18 2.95 up from 201124799%—
40Annals of Internal MedicineAmerican College of Physicians · United States
3.61Q17.14 0.73 down from 20111,3508%—
41JACC: Cardiovascular InterventionsElsevier BV · United States
3.57Q16.33 0.18 up from 2011608100%$5,000
3.55Q17.31 0.49 up from 201121915%$4,450
43Journal of the American Society of NephrologyAmerican Society of Nephrology
3.54Q18.55 0.67 down from 201188272%—
44Circulation Cardiovascular InterventionsLippincott Williams & Wilkins · United States
3.53Q17.37 0.78 up from 201129762%—
45Cochrane Database of Systematic ReviewsElsevier BV · United Kingdom
3.52Q16.71 0.26 up from 20111,39939%$5,100
46Clinical Cancer ResearchAmerican Association for Cancer Research · United States
3.52Q19.18 0.18 up from 20112,51042%—
47Arthritis & RheumatismWiley · United States
3.49Q17.57 0.71 down from 20111,57934%—
48Clinical Infectious DiseasesOxford University Press · United States
3.42Q17.84 0.54 up from 20112,11247%$4,763
49Circulation Cardiovascular ImagingLippincott Williams & Wilkins · United States
3.42Q18.02 1.46 up from 201129754%—
50IEEE Transactions on Medical ImagingInstitute of Electrical and Electronics Engineers · United States
3.40Q15.19 0.01 up from 201155734%$2,645

Citations made in 2012. Corpus-wide, 75.7% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.

1,097 additional Medicine journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2009–2011, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.

Rising journals

At a glance

Indicator year: 2012. Publication window: 2009–2011. How these summaries are calculated

Ranked journals
3,131
Window papers (baseline)
1,828,247 +21.4% from indicator year 2009
Median OJR
0.760 +2.8% from indicator year 2009
Rising journals (2025)
404Comparison-group list (404)

Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2009–2011 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.

Category by indicator year
MeasureYear series20002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025
Ranked journals1,6341,7461,8531,9332,0232,1482,2582,3902,4972,6162,7552,9493,1313,4123,6113,7603,9364,1224,3504,4874,5434,6394,6714,6924,6404,521
Window papers (baseline)709,310795,253851,873918,177953,6931,044,9181,146,4851,266,7911,370,1401,505,7841,634,0631,757,1081,828,2471,889,2311,983,2102,073,8012,149,3962,185,3782,236,1292,298,9032,395,1792,590,8562,809,1422,949,1432,961,7972,982,923
Median OJR0.480.530.560.600.610.630.680.7040.7240.7390.7560.7480.7600.7300.7490.7410.7250.7170.7010.7020.7150.6630.6550.6610.6600.67
Category context (2025)
MeasureCategory statisticEligible population
Journal self-citation shareMedian: 3.2%3,512 journals
Retracted papers per 1,000Pooled rate: 1.465 per 1,0003,472 journals
Output growthMedian: -6.9%4,166 journals
Open access shareMedian: 100.0%4,521 journals
Listed APC (USD)Median including $0 listed prices: $3,0462,526 ranked journals with a known listed price, including $0 listed prices
International collaboration shareMedian: 20.0%4,393 journals
Review shareMedian: 2.8%4,521 journals
Articles-only OJRMedian: 0.694,492 journals
Uncited shareMedian: 37.6%4,521 journals
Citation concentrationMedian: 46.3%4,514 journals

How to read these rankings

OJR, the OpenJournalRank Indicator
A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
Quartiles
Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
Impact factor (2-year)
Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
Rank ranges
Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.